These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 32264742)
1. Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity. Hirahara S; Katsumata Y; Kawasumi H; Kawaguchi Y; Harigai M Lupus; 2020 Jun; 29(7):686-696. PubMed ID: 32264742 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity. Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638 [TBL] [Abstract][Full Text] [Related]
3. Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies. Mortensen JB; Monrad I; Enemark MB; Ludvigsen M; Kamper P; Bjerre M; d'Amore F Eur J Haematol; 2021 Jul; 107(1):81-91. PubMed ID: 33721375 [TBL] [Abstract][Full Text] [Related]
4. Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis. Fukasawa T; Yoshizaki A; Ebata S; Nakamura K; Saigusa R; Miura S; Yamashita T; Hirabayashi M; Ichimura Y; Taniguchi T; Asano Y; Shimizu H; Kazoe Y; Mawatari K; Kitamori T; Sato S Arthritis Rheumatol; 2017 Sep; 69(9):1879-1890. PubMed ID: 28556548 [TBL] [Abstract][Full Text] [Related]
5. Abnormal membrane-bound and soluble programmed death ligand 2 (PD-L2) expression in systemic lupus erythematosus is associated with disease activity. Tong M; Fang X; Yang J; Wu P; Guo Y; Sun J Immunol Lett; 2020 Nov; 227():96-101. PubMed ID: 32891685 [TBL] [Abstract][Full Text] [Related]
6. Soluble forms of PD-1 and sPD-L1/2 in serum and urine of patients with head and neck cancer and their clinical significance. Lv Y; Gai K; Ding X; Sun W Biotechnol Genet Eng Rev; 2024 Nov; 40(3):2234-2245. PubMed ID: 37057626 [TBL] [Abstract][Full Text] [Related]
7. The role of PD-1/PD-Ls in the pathogenesis of IgG4-related disease. Zhang X; Lu H; Peng L; Zhou J; Wang M; Li J; Liu Z; Zhang W; Zhao Y; Zeng X; Lu L Rheumatology (Oxford); 2022 Feb; 61(2):815-825. PubMed ID: 33930105 [TBL] [Abstract][Full Text] [Related]
8. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma. Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Tominaga T; Akiyoshi T; Yamamoto N; Taguchi S; Mori S; Nagasaki T; Fukunaga Y; Ueno M PLoS One; 2019; 14(2):e0212978. PubMed ID: 30807610 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma. Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467 [TBL] [Abstract][Full Text] [Related]
11. The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus-A Pilot Study. Király Z; Nagy E; Bokor L; Kovács A; Marschalkó M; Hidvégi B J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685714 [TBL] [Abstract][Full Text] [Related]
12. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19 Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542 [TBL] [Abstract][Full Text] [Related]
13. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma. Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460 [TBL] [Abstract][Full Text] [Related]
14. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis]. Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637 [No Abstract] [Full Text] [Related]
15. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus]. Luo L; Shu M; Li S; Cai Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624 [TBL] [Abstract][Full Text] [Related]
16. The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma. Akutsu Y; Murakami K; Kano M; Toyozumi T; Matsumoto Y; Takahashi M; Otsuka R; Sekino N; Yokoyama M; Shiraishi T; Matsubara H Esophagus; 2018 Apr; 15(2):103-108. PubMed ID: 29892935 [TBL] [Abstract][Full Text] [Related]
17. Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis. Wasén C; Erlandsson MC; Bossios A; Ekerljung L; Malmhäll C; Töyrä Silfverswärd S; Pullerits R; Lundbäck B; Bokarewa MI Front Immunol; 2018; 9():1677. PubMed ID: 30140263 [TBL] [Abstract][Full Text] [Related]
18. Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis. Cai L; Zhang C; Wu J; Zhou W; Chen T Clin Immunol; 2021 Aug; 229():108800. PubMed ID: 34289424 [TBL] [Abstract][Full Text] [Related]
19. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer]. Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus. Her M; Kim D; Oh M; Jeong H; Choi I Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]